Current developments in interstitial lung disease

Abstract

This supplement is intended to focus on interstitial lung disease. New treatment advances, clinical approaches to patients with interstitial lung disease (ILD) and end-points to measure improvement in clinical studies are included within the supplement’s scope. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine aims to provide researchers working in this complex, quickly developing field with online, open access to highly relevant scholarly articles by leading international researchers. In a field where the literature is ever-expanding, researchers increasingly need access to up-to-date, high quality scholarly articles on areas of specific contemporary interest. This supplement aims to address this by presenting high-quality articles that allow readers to distinguish the signal from the noise. The editor in chief hopes that through this effort, practitioners and researchers will be aided in finding answers to some of the most complex and pressing issues of our time. Articles should focus on ILD and may include the following topics: • New advances in ILD • Clinical approaches to patients with ILD • End-points to measure improvement in clinical studies.